SynBioBeta Speaker
Geoff Hamilton
Chief Business & CFO
Ansa Biotechnologies
May 2026, SynBioBeta
Speaker
Geoff Hamilton is the Chief Business and Chief Financial Officer of Ansa Biotechnologies, a leading provider of gene synthesis products powering the next era of medicines and engineered biology. Geoff has a 24 year career in the industry spanning life science tools, genomics, and therapeutics. Geoff has been a leader in developing and launching revolutionary technologies in next-generation sequencing and applying gene and cell engineering tools to develop breakthrough therapeutics. Prior to joining Ansa, Geoff was the cofounder and CEO of Stemson Therapeutics, a cell therapy company developing regenerative treatments for skin diseases and hair loss conditions. Prior to founding Stemson, he spent six years at Illumina where he held leadership positions in product commercialization, clinical marketing, sequencing application strategy, and product portfolio management. Before Illumina, Geoff spent a decade at Life Technologies, a leading provider of tools, reagents, and analytical instruments before it was acquired by ThermoFisher Scientific. At Life Tech, he held a number of finance, marketing, commercial, and acquisition leadership roles.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.